Alpha 2.0
Login Register
» Articles » PMID: 19797538

Exposure to Hydroxyurea During Pregnancy in Sickle-beta Thalassemia: a Report of 2 Cases

Overview
Journal J Clin Pharmacol
Publisher Wiley
Specialty Pharmacology
Date 2009 Oct 3
PMID 19797538
Citations 4
Authors
Khushnooma Y Italia
Farah F Jijina
S Chandrakala
Anita H Nadkarni
Pratibha Sawant
Kanjaksha Ghosh
Roshan B Colah
Affiliations
Soon will be listed here.
Citing Articles

Impact of hydroxyurea on follicle density in patients with sickle cell disease.

Diesch-Furlanetto T, Sanchez C, Atkinson A, Pondarre C, Dhedin N, Neven B Blood Adv. 2024; 8(19):5227-5235.

PMID: 39023361 PMC: 11530394. DOI: 10.1182/bloodadvances.2023011536.

Outcomes of Pregnancy in Sickle Cell Disease Patients: Results from the Prospective ESCORT-HU Cohort Study.

Habibi A, Cannas G, Bartolucci P, Voskaridou E, Joseph L, Bernit E Biomedicines. 2023; 11(2).

PMID: 36831132 PMC: 9953329. DOI: 10.3390/biomedicines11020597.

A systematic review on hydroxyurea therapy for sickle cell disease in India.

Pandey A, Kaur H, Borah S, Khargekar N, Karra V, Adhikari T Indian J Med Res. 2023; 156(2):299-311.

PMID: 36629190 PMC: 10057355. DOI: 10.4103/ijmr.ijmr_3447_21.

A successful twin pregnancy in a patient with HbE-β-thalassemia in western India.

Merchant R, Italia K, Ahmed J, Ghosh K, Colah R J Postgrad Med. 2015; 61(3):203-5.

PMID: 26119442 PMC: 4943415. DOI: 10.4103/0022-3859.159427.